01/26
Headlines

NASDAQ:BIIB

Morning Buzz : Twitter (NYSE:TWTR), Conversant (NASDAQ:CNVR), Biogen Idec (NASDAQ:BIIB), Toyota Motor Corporation (NYSE:TM), Home Bancorp, Inc. (NASDAQ:HBCP)

Chris Lewis03 mins

Twitter Inc. (NYSE:TWTR) released its 10-Q filing with the Securities and Exchange Commission (SEC) today, saying that 11% of its users were accessing the microblogging platform using third-party apps, compared to the 14% it reported in its second-quarter (2QFY14) earnings. Because third-party app users do not see ads on the platform, the decline in fact…

Read More

Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Mark DeFrance03 mins

Drugmaker Vivus Inc. (NASDAQ:VVUS) said Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of company’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -0.19% in last session and…

Read More

Investor’s Watch List: Zillow Inc (NASDAQ:Z), Pacific Ethanol (NASDAQ:PEIX), Biogen Idec Inc (NASDAQ:BIIB), The Kroger Co. (NYSE:KR)

Jason Knox02 mins

Zillow, Inc. (NASDAQ:Z), the leading real estate information marketplace, today announced it entered into an exclusive partnership with Beijing Yisheng Leju Information Services Co. (“Leju”), an affiliate of E-House (China) Holdings Limited (NYSE: EJ), a leading real estate services company in China, to power Leju’s U.S. home shopping experience. Zillow Inc (NASDAQ:Z) stock performance was…

Read More

Trending Stocks: Biogen Idec (NASDAQ:BIIB), The Procter & Gamble (NYSE:PG), Epizyme Inc (NASDAQ:EPZM), Johnson & Johnson (NYSE:JNJ)

Jason Knox02 mins

Biogen Idec Inc. (NASDAQ:BIIB) announced it will report first quarter 2014 financial results on Wednesday, April 23, 2014, before the financial markets open. Biogen Idec Inc (NASDAQ:BIIB) stock performance was 1.28% in last session and finished the day at $309.79. Traded volume was 1.71million shares in the last session and the average volume of the…

Read More

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman02 mins

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1…

Read More